MEDICUS PHARMA LTD. Investment Income, Net
MEDICUS PHARMA LTD. (MDCX) reported Investment Income, Net of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-12
- MEDICUS PHARMA LTD. investment income, net for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- MEDICUS PHARMA LTD. investment income, net for the quarter ending 2026-03-31 was $56.56K, a 136.99% increase year-over-year.
- MEDICUS PHARMA LTD. investment income, net for the quarter ending 2025-06-30 was $40.00K.
- MEDICUS PHARMA LTD. investment income, net for the quarter ending 2025-03-31 was $23.87K.
- MEDICUS PHARMA LTD. investment income, net for fiscal 2024 was $25.39K.
- MEDICUS PHARMA LTD. investment income, net for fiscal 2023 was -$584.82K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $56.56K 10-Q · filed 2026-05-14 | ||
| 2025-06-30 | $40.00K 10-Q · filed 2026-08-12 | $63.87K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $23.87K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $25.39K 10-K · filed 2025-03-28 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | ||
| 2023-12-31 | -$584.82K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |